Exon Skipping Prevents Formation of Toxic Protein Fragments in Huntington's Disease

An innovative therapeutic strategy for reducing the levels of toxic protein fragments associated with Huntington's disease uses a new approach called exon skipping to remove the disease-causing component of the essential protein, huntingtin. Proof of concept using antisense oligonucleotides to “skip over” the specific exon in a mouse model of Huntington's disease is reported in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article, part of a special focus issue on exon skipping, is available free on the Nucleic Acid Therapeutics website.

Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...